Sat , May 17, 2025
Newsletter
Home > AZ Cannabis News > DEA Wants FDA to Reschedule Marijuana

DEA Wants FDA to Reschedule Marijuana


đź’° Save Money. Get Deals. đź’°


Get cannabis deals. It's free ⤵️



100% free. Cancel anytime.


FDA Medical Marijuana
The Food and Drug Administration (FDA) is conducting an analysis at the Drug Enforcement Administration’s (DEA) request on whether the United States should downgrade the classification of marijuana from a Schedule 1 drug, said Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing.

The FDA reviewed the status of marijuana for the DEA in 2001 and 2006 and recommended it remain a Schedule 1 substance. The DEA has since been petitioned to change the classification of marijuana. “We’re in the process of conducting an eight-factor analysis,” said Throckmorton.

Throckmorton would not say when he expects the FDA to complete its analysis or whether it would recommend a change. The agency would first consult with the National Institute on Drug Abuse and then send the recommendation through the Department of Health and Human Services before handing it to the DEA.

Read more marijuana news.


⚡️


Arizona legalized marijuana for recreational use in November 2020. The law allows adults aged 21+ to purchase, possess and use cannabis. State-licensed cannabis dispensaries began selling recreational marijuana in early 2021. There are over 150 dispensaries in Arizona — a majority of them are in populous areas such as Phoenix, Tucson and Flagstaff. Recreational cannabis delivery services began operating in 2024.  


AZ Cannabis Updates